Alvotech SA, a global biotech company specializing in biosimilar medicines, will participate in the Goldman Sachs 46th Global Healthcare Conference in Miami from June 9-11, 2025. The company's management team will host one-on-one meetings, and Dr. Balaji Prasad, Chief Strategy Officer, will participate in a fireside chat on June 11 at 8:00 am EDT. A live webcast of the chat will be available to the public.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.